CCND1 G870A polymorphism contributes to the risk of esophageal cancer: An updated systematic review and cumulative meta?analysis

Wen,Li; Hu,Yuan‑Yuan; Yang,Gong‑Li; Liu,De‑Xi

doi:10.3892/br.2014.286

CCND1 G870A polymorphism contributes to the risk of esophageal cancer: An updated systematic review and cumulative meta?analysis

Authors:
- Li Wen
- Yuan‑Yuan Hu
- Gong‑Li Yang
- De‑Xi Liu
View Affiliations

Affiliations: Department of Dermatology, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, P.R. China, Department of Stomatology and Evidence‑Based Medicine Center, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, P.R. China, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Baiyun, Guangzhou 510515, P.R. China
Published online on: May 21, 2014 https://doi.org/10.3892/br.2014.286
Pages: 549-554

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The common functional cyclin D1 (CCND1) G870A polymorphism may influence the risk of esophageal cancer. However, the conclusions of previous studies have been inconsistent for the association between the CCND1 G870A polymorphism and esophageal cancer risk. A meta?analysis of 11 published case?control studies was performed, including 2,111 patients with esophageal cancer and 3,232 controls, to investigate the association between the CCND1 G870A polymorphism and esophageal cancer risk. The odds ratio (OR) with a 95% confidence interval (CI) was applied to assess the association between the CCND1 G870A polymorphism and esophageal cancer risk. A significant association between the CCND1 G870A polymorphism and esophageal cancer risk was observed for the allele contrast (A vs. G: OR, 1.23; 95% CI, 1.02?1.48; P=0.029), codominant (AA vs. GG: OR, 1.58; 95% CI; 1.06?2.35; P=0.024) and recessive models (AA vs. GG + GA: OR, 1.33, 95% CI, 1.03?1.73; P=0.030). However, in the stratified analysis by ethnicity, study design and pathology, there was no significant association detected in these genetic models. In conclusion, results of the meta?analysis suggested that the CCND1 G870A polymorphism is a potential risk factor in the development of esophageal cancer.

View Figures

View References

1	Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
2	Keszei AP, Schouten LJ, Goldbohm RA and van den Brandt PA: Red and processed meat consumption and the risk of esophageal and gastric cancer subtypes in The Netherlands Cohort Study. Ann Oncol. 23:2319–2326. 2012. View Article : Google Scholar : PubMed/NCBI
3	Steevens J, Schouten LJ, Goldbohm RA and van den Brandt PA: Vegetables and fruits consumption and risk of esophageal and gastric cancer subtypes in the Netherlands cohort study. Int J Cancer. 129:2681–2693. 2011. View Article : Google Scholar : PubMed/NCBI
4	Bravi F, Edefonti V, Randi G, et al: Dietary patterns and the risk of esophageal cancer. Ann Oncol. 23:765–770. 2012. View Article : Google Scholar : PubMed/NCBI
5	Sherr CJ: Cancer cell cycles. Science. 274:1672–1677. 1996. View Article : Google Scholar : PubMed/NCBI
6	Zhao J, Li L, Wei S, et al: Clinicopathological and prognostic role of cyclin D1 in esophageal squamous cell carcinoma: a meta-analysis. Dis Esophagus. 25:520–526. 2011. View Article : Google Scholar : PubMed/NCBI
7	Kaminagakura E, Werneck da Cunha I, Soares FA, Nishimoto IN and Kowalski LP: CCND1 amplification and protein overexpression in oral squamous cell carcinoma of young patients. Head Neck. 33:1413–1419. 2011. View Article : Google Scholar : PubMed/NCBI
8	Troncone G, Volante M, Iaccarino A, et al: Cyclin D1 and D3 overexpression predicts malignant behavior in thyroid fine-needle aspirates suspicious for Hurthle cell neoplasms. Cancer. 117:522–529. 2009.PubMed/NCBI
9	Abramson VG, Troxel AB, Feldman M, et al: Cyclin D1b in human breast carcinoma and coexpression with cyclin D1a is associated with poor outcome. Anticancer Res. 30:1279–1285. 2010.PubMed/NCBI
10	Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD and Heighway J: Alternate splicing produces a novel cyclin D1 transcript. Oncogene. 11:1005–1011. 1995.PubMed/NCBI
11	Li Z, Jiao X, Wang C, et al: Alternative cyclin D1 splice forms differentially regulate the DNA damage response. Cancer Res. 70:8802–8811. 2010. View Article : Google Scholar : PubMed/NCBI
12	Cai W, Wang ZT, Zhong J and Zhang Y: Lack of association between Cyclin D1 gene G870A polymorphism and esophageal cancer: evidence from a meta-analysis. Genet Mol Res. 12:6636–6645. 2013. View Article : Google Scholar : PubMed/NCBI
13	Zhou X, Gu Y and Zhang SL: Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: a HuGE review and meta-analysis. Asian Pac J Cancer Prev. 13:4909–4914. 2012. View Article : Google Scholar : PubMed/NCBI
14	Little J, Bradley L, Bray MS, et al: Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol. 156:300–310. 2002. View Article : Google Scholar : PubMed/NCBI
15	Lau J, Ioannidis JP and Schmid CH: Quantitative synthesis in systematic reviews. Ann Intern Med. 127:820–826. 1997. View Article : Google Scholar : PubMed/NCBI
16	Mantel N and Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
17	DerSimonian R and Laird N: Meta-analysis in clinical trials. Control Clin Trials. 7:177–188. 1986. View Article : Google Scholar : PubMed/NCBI
18	Harbord RM, Egger M and Sterne JA: A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 25:3443–3457. 2006. View Article : Google Scholar : PubMed/NCBI
19	Egger M, Davey Smith G, Schneider M and Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
20	Yu C, Lu W, Tan W, et al: Lack of association between CCND1 G870A polymorphism and risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 12:1762003.PubMed/NCBI
21	Zhang J, Li Y, Wang R, et al: Association of cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population. Int J Cancer. 105:281–284. 2003. View Article : Google Scholar : PubMed/NCBI
22	Casson AG, Zheng Z, Evans SC, et al: Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma. Cancer. 104:730–739. 2005. View Article : Google Scholar : PubMed/NCBI
23	Geddert H, Kiel S, Zotz RB, et al: Polymorphism of p16 INK4A and cyclin D1 in adenocarcinomas of the upper gastrointestinal tract. J Cancer Res Clin Oncol. 131:803–808. 2005. View Article : Google Scholar : PubMed/NCBI
24	Jain M, Kumar S, Lal P, Tiwari A, Ghoshal UC and Mittal B: Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer. Cancer Detect Prev. 31:225–232. 2007. View Article : Google Scholar : PubMed/NCBI
25	Liu G, Cescon DW, Zhai R, et al: p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma. Dis Esophagus. 23:36–39. 2010. View Article : Google Scholar : PubMed/NCBI
26	Kurmano BK, Djansugurova L, Bersimba R, et al: TP53 Arg72Pro and CCND1 A870G polymorphisms and esophageal cancer risk. J Life Sci. 4:16–20. 2010.
27	Hussain S, Yuvaraj M, Thakur N, et al: Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley: a high risk area. Mol Carcinog. 50:487–498. 2011. View Article : Google Scholar : PubMed/NCBI
28	Akbari MR, Malekzadeh R, Shakeri R, et al: Candidate gene association study of esophageal squamous cell carcinoma in a high-risk region in Iran. Cancer Res. 69:7994–8000. 2009. View Article : Google Scholar : PubMed/NCBI
29	Djansugurova LB, Perfilyeva AV, Zhunusova GS, Djantaeva KB, Iksan OA and Khussainova EM: The determination of genetic markers of age-related cancer pathologies in populations from Kazakhstan. Front Genet. 4:702013. View Article : Google Scholar : PubMed/NCBI
30	Hall M and Peters G: Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res. 68:67–108. 1996. View Article : Google Scholar : PubMed/NCBI
31	Solomon DA, Wang Y, Fox SR, et al: Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem. 278:30339–30347. 2003. View Article : Google Scholar : PubMed/NCBI
32	Sergentanis TN and Economopoulos KP: Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls. Mol Biol Rep. 38:4955–4963. 2011. View Article : Google Scholar : PubMed/NCBI
33	Comstock CE, Augello MA, Benito RP, et al: Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer. Clin Cancer Res. 15:5338–5349. 2009. View Article : Google Scholar : PubMed/NCBI
34	Yaylim-Eraltan I, Arikan S, Yildiz Y, et al: The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population. Anticancer Res. 30:2875–2880. 2010.PubMed/NCBI
35	Tsai MH, Tsai CW, Tsou YA, Hua CH, Hsu CF and Bau DT: Significant association of cyclin D1 single nucleotide polymorphisms with oral cancer in taiwan. Anticancer Res. 31:227–231. 2011.PubMed/NCBI
36	Akkiz H, Bayram S, Bekar A, Akgöllü E and Ozdil B: Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study. Cancer Epidemiol. 34:298–302. 2010. View Article : Google Scholar : PubMed/NCBI
37	Cai W, Wang ZT, Zhong J and Zhang Y: Lack of association between Cyclin D1 gene G870A polymorphism and esophageal cancer: evidence from a meta-analysis. Genet Mol Res. 12:6636–6645. 2013. View Article : Google Scholar : PubMed/NCBI
38	Zhuo W, Zhang L, Wang Y, Zhu B and Chen Z: Cyclin D1 G870A polymorphism is a risk factor for esophageal cancer among Asians. Cancer Invest. 30:630–636. 2012. View Article : Google Scholar : PubMed/NCBI